MatthewA(A)BennettMD

PubMed

• Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase
  Raymond F. Schinazi, Ivana Massud, Kimberly L. Rapp, Meta Cristiano, Mervi Detorio, Richard A. Stanton, Matthew A. Bennett, Monique Kierlin-Duncan, Johan Lennerstrand,...> ;Antimicrobial Agents and Chemotherapy. 2011 May 1
• Combinations of 2′-C-methylcytidine analogues with interferon-α2b and triple combination with ribavirin in the hepatitis C virus replicon system
  Leda Bassit, Jason Grier, Matthew A. Bennett, Raymond F. Schinazi> ;Antiviral Chemistry & Chemotherapy. 2008 Feb 1
• Inhibition of hepatitis C replicon RNA synthesis by beta-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication
  Lieven Stuyver, Tamara R. McBrayer, Phillip M. Tharnish, Jeremy L. Clark, Laurent Hollecker, Stefania Lostia, Tammy Nachman, Jason Grier, Matthew A. Bennett, Meng-Yu X...> ;Antiviral Chemistry & Chemotherapy. 2006 Apr 1
• Reverse two-hybrid techniques in the yeast Saccharomyces cerevisiae.
  Bennett, M.A., Shern, J.F., Kahn, R.A.> ;Methods Mol Biol. 2004
• Generation of antibodies to cell surface markers on mature natural killer cells.
  Lai WC, Zhang Y, George T, Sivakumar PV, Stepp S, Zhou D, Bennett M, Kumar V, Schatzle J> ;Methods Mol. Biol.. 2000-01-01
• Hybrid resistance by mouse NK cells in vitro.
  Sivakumar PV, George T, Puzanov IJ, Williams NS, Stepp S, Liu J, Schatzle J, Lai WC, Bennett M, Kumar V> ;Methods Mol. Biol.. 2000-01-01
• Chemotherapeutic properties of coumermycin A1.
  Grunberg E, Bennett M> ;Antimicrob. Agents Chemother.. 1965-01-01
• Join now to see all